Credit Agricole’s Microbot Medical MBOT Stock Holding History

Credit Agricole’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	554
2019 Q4	$0	Hold	1	–	–	﹤0.01%	550
2019 Q3	$0	Buy	+1	New	+$6	﹤0.01%	586

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Credit Agricole's MBOT Position: Q1 2020 in Review

Credit Agricole sold out of Microbot Medical (MBOT) in Q1 2020, closing a stake of 1 share.

Credit Agricole first reported a position in MBOT in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 29 funds tracked by Wall St. Rank hold MBOT as of Q1 2020.

Credit Agricole reported no remaining Microbot Medical position as of Q1 2020 after selling out during the quarter.
Credit Agricole sold 1 Microbot Medical share in Q1 2020.
Credit Agricole first reported a position in Microbot Medical in Q3 2019 and held it in 2 quarters.
Credit Agricole's Microbot Medical position peaked at $0 in Q4 2019.
29 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2020.

Based on Credit Agricole's 13F filing for Q1 2020, filed 14 May 2020.